TWi Biotechnology, Inc. 6610.TWO Stock
TWi Biotechnology, Inc. Price Chart
TWi Biotechnology, Inc. 6610.TWO Financial and Trading Overview
| TWi Biotechnology, Inc. stock price | 12.75 TWD |
| Previous Close | 17.6 TWD |
| Open | 17.65 TWD |
| Bid | 17.7 TWD x 0 |
| Ask | 18.1 TWD x 0 |
| Day's Range | 17.6 - 18 TWD |
| 52 Week Range | 10.75 - 26 TWD |
| Volume | 91K TWD |
| Avg. Volume | 144.19K TWD |
| Market Cap | 1.2B TWD |
| Beta (5Y Monthly) | 0.701369 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.33 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6610.TWO Valuation Measures
| Enterprise Value | 1.04B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 5.83004 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -12.582 |
Trading Information
TWi Biotechnology, Inc. Stock Price History
| Beta (5Y Monthly) | 0.701369 |
| 52-Week Change | 21.79% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 26 TWD |
| 52 Week Low | 10.75 TWD |
| 50-Day Moving Average | 19.74 TWD |
| 200-Day Moving Average | 16.4 TWD |
6610.TWO Share Statistics
| Avg. Volume (3 month) | 144.19K TWD |
| Avg. Daily Volume (10-Days) | 99.19K TWD |
| Shares Outstanding | 67.83M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -20.66% |
| Return on Equity (ttm) | -31.43% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -82342000 TWD |
| Net Income Avi to Common (ttm) | -76177000 TWD |
| Diluted EPS (ttm) | -1.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 160.4M TWD |
| Total Cash Per Share (mrq) | 2.37 TWD |
| Total Debt (mrq) | 2.53M TWD |
| Total Debt/Equity (mrq) | 1.23 TWD |
| Current Ratio (mrq) | 6.319 |
| Book Value Per Share (mrq) | 3.036 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -60241000 TWD |
| Levered Free Cash Flow (ttm) | -40336000 TWD |
Profile of TWi Biotechnology, Inc.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 41, Lane 221 |
| ZIP | 11494 |
| Phone | 886 2 2657 1788 |
| Website | https://www.twibiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 19 |
TWi Biotechnology, Inc., a clinical-stage biopharmaceutical company, develops and sells drugs for innate immunity-related diseases in Taiwan. The company provides AC-203, which is in Phase 2 clinical trial for various indications, including epidermolysis bullosa simplex, bullous pemphigoid, and epidermolysis bullosa; AC-701 that is in Phase 2 clinical trial to treat various inflammatory skin diseases; and AC- 1101, which is in Phase 1 trial for the treatment of vitiligo, as well as in preclinical stage for the treatment of atopic dermatitis. It has a strategic partnership with Hongkong Winhealth Pharma Group granting Winhealth Pharma exclusive right to develop and commercialize rare disease asset AC-203 for various indications, including hereditary epidermolysis bullosa, bullous pemphigoid, and other skin diseases in Mainland China, Hong Kong, and Macao. The company was founded in 2010 and is based in Taipei, Taiwan.
Q&A For TWi Biotechnology, Inc. Stock
What is a current 6610.TWO stock price?
TWi Biotechnology, Inc. 6610.TWO stock price today per share is 12.75 TWD.
How to purchase TWi Biotechnology, Inc. stock?
You can buy 6610.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for TWi Biotechnology, Inc.?
The stock symbol or ticker of TWi Biotechnology, Inc. is 6610.TWO.
Which industry does the TWi Biotechnology, Inc. company belong to?
The TWi Biotechnology, Inc. industry is Biotechnology.
How many shares does TWi Biotechnology, Inc. have in circulation?
The max supply of TWi Biotechnology, Inc. shares is 87.65M.
What is TWi Biotechnology, Inc. Price to Earnings Ratio (PE Ratio)?
TWi Biotechnology, Inc. PE Ratio is now.
What was TWi Biotechnology, Inc. earnings per share over the trailing 12 months (TTM)?
TWi Biotechnology, Inc. EPS is -2.33 TWD over the trailing 12 months.
Which sector does the TWi Biotechnology, Inc. company belong to?
The TWi Biotechnology, Inc. sector is Healthcare.